These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 26671736)
1. Young investigator challenge: Application of cytologic techniques to circulating tumor cell specimens: Detecting activation of the oncogenic transcription factor STAT3. Lowe AC; Pignon JC; Carvo I; Drage MG; Constantine NM; Jones N; Kroll Y; Frank DA; Signoretti S; Cibas ES Cancer Cytopathol; 2015 Dec; 123(12):696-706. PubMed ID: 26671736 [TBL] [Abstract][Full Text] [Related]
2. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis. Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331 [TBL] [Abstract][Full Text] [Related]
4. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study. Rink M; Chun FK; Dahlem R; Soave A; Minner S; Hansen J; Stoupiec M; Coith C; Kluth LA; Ahyai SA; Friedrich MG; Shariat SF; Fisch M; Pantel K; Riethdorf S Eur Urol; 2012 Apr; 61(4):810-7. PubMed ID: 22277196 [TBL] [Abstract][Full Text] [Related]
5. Circulating Tumor Cells: Overview and Opportunities in Cytology. Sundling KE; Lowe AC Adv Anat Pathol; 2019 Jan; 26(1):56-63. PubMed ID: 30325755 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of transcription-reverse transcription concerted reaction method for detecting circulating tumor cells in patients with colorectal cancer. Sato N; Hayashi N; Imamura Y; Tanaka Y; Kinoshita K; Kurashige J; Saito S; Karashima R; Hirashima K; Nagai Y; Miyamoto Y; Iwatsuki M; Baba Y; Watanabe M; Baba H Ann Surg Oncol; 2012 Jun; 19(6):2060-5. PubMed ID: 21732137 [TBL] [Abstract][Full Text] [Related]
7. Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics. Onstenk W; Gratama JW; Foekens JA; Sleijfer S Cancer Treat Rev; 2013 Nov; 39(7):691-700. PubMed ID: 23683721 [TBL] [Abstract][Full Text] [Related]
8. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Riethdorf S; Fritsche H; Müller V; Rau T; Schindlbeck C; Rack B; Janni W; Coith C; Beck K; Jänicke F; Jackson S; Gornet T; Cristofanilli M; Pantel K Clin Cancer Res; 2007 Feb; 13(3):920-8. PubMed ID: 17289886 [TBL] [Abstract][Full Text] [Related]
9. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system. Andreopoulou E; Yang LY; Rangel KM; Reuben JM; Hsu L; Krishnamurthy S; Valero V; Fritsche HA; Cristofanilli M Int J Cancer; 2012 Apr; 130(7):1590-7. PubMed ID: 21469140 [TBL] [Abstract][Full Text] [Related]
10. Detection and Characterization of Circulating Tumor Cells by the CellSearch Approach. Coumans F; Terstappen L Methods Mol Biol; 2015; 1347():263-78. PubMed ID: 26374323 [TBL] [Abstract][Full Text] [Related]
11. Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry. Takao M; Takeda K Cytometry A; 2011 Feb; 79(2):107-17. PubMed ID: 21246706 [TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1α in human gastric cancer. Woo S; Lee BL; Yoon J; Cho SJ; Baik TK; Chang MS; Lee HE; Park JW; Kim YH; Kim WH Pathobiology; 2011; 78(6):295-301. PubMed ID: 22104200 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancer. Jaeger BA; Jueckstock J; Andergassen U; Salmen J; Schochter F; Fink V; Alunni-Fabbroni M; Rezai M; Beck T; Beckmann MW; Friese K; Friedl TW; Janni W; Rack B Biomed Res Int; 2014; 2014():491459. PubMed ID: 24800234 [TBL] [Abstract][Full Text] [Related]
14. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503 [TBL] [Abstract][Full Text] [Related]
17. Nanobiotechnology for the capture and manipulation of circulating tumor cells. Hughes AD; King MR Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(3):291-309. PubMed ID: 22162415 [TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score. Kolostova K; Broul M; Schraml J; Cegan M; Matkowski R; Fiutowski M; Bobek V Anticancer Res; 2014 Jul; 34(7):3641-6. PubMed ID: 24982381 [TBL] [Abstract][Full Text] [Related]
19. New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use. Becker TM; Caixeiro NJ; Lim SH; Tognela A; Kienzle N; Scott KF; Spring KJ; de Souza P Int J Cancer; 2014 Jun; 134(11):2523-33. PubMed ID: 24122526 [TBL] [Abstract][Full Text] [Related]
20. Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours. Lai R; Rassidakis GZ; Medeiros LJ; Leventaki V; Keating M; McDonnell TJ J Pathol; 2003 Jan; 199(1):84-9. PubMed ID: 12474230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]